
Zymergen
» see zymergen.com as it lived, on the wayback machine
~ the eulogy ~
Zymergen was incorporated in Delaware on 24 April 2013 and built in Emeryville, California by Josh Hoffman, who came from banking, with two scientists out of Amyris: Zach Serber and Jed Dean. The pitch was that biology had become an engineering discipline and could therefore be industrialized. Zymergen would run enormous automated screens on engineered microbes and manufacture materials by fermentation rather than petrochemistry. It called this biofacturing. Investors liked it a great deal: $44 million from DCVC in 2015, $130 million from SoftBank in 2016, $406 million led by the SoftBank Vision Fund in 2018, and $300 million more in September 2020 led by Baillie Gifford. Something close to $930 million before it ever sold a product.
The product, when it came, was Hyaline, launched in December 2020. It was an optical film intended for the folding screens that phone makers were then promising, clear enough to see through and tough enough to survive being creased a few hundred thousand times. Zymergen went public on the Nasdaq on 22 April 2021 at $31.00 a share, raising about $575 million once the underwriters took their extra allocation, which valued it around $3 billion.
Fifteen weeks later it was over. Josh Hoffman separated as chief executive on 2 August 2021 and Jay Flatley, formerly of Illumina, took the chair as acting chief. On 3 August, after the market closed, the company issued a business update saying that several key target customers had hit technical problems putting Hyaline into their own manufacturing lines, and that emerging data showed the foldable display market was smaller and slower-growing than it had assumed. It no longer expected any product revenue in 2021, or anything material in 2022. The next day the stock lost more than 76 percent and closed at $8.25.
Nobody outside the company and its shareholders ever used anything Zymergen made, which puts it on the far side of any distance I could claim. The one piece of it that was supposed to reach ordinary people was a film in a phone you would unfold on a bus. Foldable phones did eventually arrive, with somebody else's film in them. What is left of Zymergen is a prospectus and a stack of layoff notices.
~ the dossier ~
| Born | incorporated in Delaware on 24 April 2013, built in Emeryville, California |
|---|---|
| Peak | $48.50 a share and about $4.8 billion of market value in April 2021, on 762 staff |
| Killed | 19 October 2022, its last day trading as itself |
| Lifespan | 9 years, 18 months of them public |
| Made by | Josh Hoffman with Zach Serber and Jed Dean, two scientists out of Amyris |
| Killed by | a single product aimed at a market that was not there yet |
~ hyaline ~
The film was the company's first and only commercial product, and the market sizing behind it leaned on an industry forecast that foldable shipments would go from half a million units in 2019 to more than eighty million a year by 2025. That did not happen on anything like that curve.
There is a sentence in the IPO prospectus worth more than the rest of the document. To get Hyaline out quickly, Zymergen launched it using a biomolecule that was not produced by fermentation at all, bought from a third party, with conversion to its own process expected to finish in 2022. The flagship product of a company whose entire thesis was manufacturing by biology was, on the day it shipped, not manufactured by biology. On 3 November 2021 the electronics film programs were discontinued outright, keeping only one compound being developed with Sumitomo Chemical, and about 220 positions went with them.
~ the warning was in the filing ~
The IPO prospectus, dated 21 April 2021, disclosed substantial doubt about the company's ability to continue as a going concern as of the end of 2020. It also disclosed a net loss of $262 million for that year against roughly $13 million of revenue, all of it research services rather than products.
The Securities and Exchange Commission settled a cease-and-desist order against the company on 13 September 2024 for a $30 million penalty, finding that Zymergen had rested a claimed billion-dollar market opportunity on unreasonable assumptions and had handed analysts revenue forecasts well above its own internal numbers. The order also found it had misdescribed the Hyaline customer pipeline on its first public earnings call. The regional director's summary of it was unsupported hype. Only about $7.7 million of the penalty was ever collected from the estate.
~ the long burial ~
Ginkgo Bioworks agreed to buy Zymergen on 24 July 2022, all in stock, at 0.9179 Ginkgo shares for each Zymergen share. The headline called it a $300 million deal; by the time it closed on 19 October 2022 the consideration was worth about $236 million. Nasdaq suspended the ticker that day at the company's own request. An investor who bought at the IPO was holding roughly $2.24 of Ginkgo for every $31.00 they had paid eighteen months earlier.
Ginkgo kept the automation platform and the software and let the rest go. In September 2023 the Emeryville campus was abandoned, around 300,000 square feet on a lease that ran to 2033, with a $96 million impairment against it. Ginkgo deconsolidated the subsidiary on 2 October 2023 and Zymergen filed Chapter 11 in Delaware the next day, with Ginkgo as stalking horse for the intellectual property at $5 million in cash. That sale completed on 18 January 2024, a liquidation plan was confirmed on 5 February, and on 23 February 2024 every remaining interest in the Zymergen entities was extinguished. The ten California layoff notices filed across those years add up to 619 people; the last one took effect on 18 December 2023.
~ leave a rose ~
an anonymous tribute. one rose per visitor per day.
@}-->-- ... roses left here
~ leave a wreath ~
a rose fades by morning. a wreath stays on this grave for good, with your name on it.
paid once through stripe. payments are handled by OÜ Lakeview, the small company that keeps rip.so running. the money pays for the hosting and the nightly digging. adopt it and the headstone reads "maintained in memory by" you. the groundskeeper plants new wreaths at the next tending, usually within a day.
» one email a week: new graves and the anniversaries of the dead. subscribe
other dot com: LetsBuyIt.com, ComputerLand, MightyWords, Furniture.com
also died in the 2020s: Telex, Atrium, Mediavideo
~ leave a note ~
visitors before you have left these graveside notes. anonymous welcome.